Transformation of myelodysplastic syndrome (MDS) to acute myeloid leukaemia (AML)
Myelodysplastic syndrome (MDS) is a clonal haematopoietic stem cell disorder characterised by ineffective haematopoiesis. Patients with MDS have a probability of transforming to Acute Myeloid Leukaemia (AML). To better understand the transformation of MDS to AML in Singapore, a retrospective multiva...
Main Author: | Goh, Chermaine Yu Zhen |
---|---|
Other Authors: | - |
Format: | Final Year Project (FYP) |
Language: | English |
Published: |
Nanyang Technological University
2021
|
Subjects: | |
Online Access: | https://hdl.handle.net/10356/152330 |
Similar Items
-
Elucidating the genomic and transcriptomic profiles contributing to the overall survival of acute myeloid leukaemia patients with normal karyotype in Malaysia
by: Ambayya @ Ampiah, A Angeli
Published: (2024) -
Real-world effectiveness of azacitidine in treatment-naive patients with higher-risk myelodysplastic syndromes
by: Rajakumaraswamy, N, et al.
Published: (2023) -
Generalized GM-MDS: Polynomial Codes Are Higher Order MDS
by: Brakensiek, Joshua, et al.
Published: (2024) -
Transcriptional regulation of type I interferon responses of myeloid antigen presenting cells
by: Sin, Wei Xiang
Published: (2016) -
Magrolimab in combination with azacitidine in patients with higher-risk myelodysplastic syndromes: final results of a phase Ib study
by: Sallman, DA, et al.
Published: (2023)